Preventing HIV infection with anti-HIV drugs in people at risk is cost-effective
Tuesday, March 12, 2013 - 17:00
in Health & Medicine
An HIV prevention strategy in which people at risk of becoming exposed to HIV take antiretroviral drugs to reduce their chance of becoming infected (often referred to as pre-exposure prophylaxis or PrEP), may be a cost-effective method of preventing HIV in some settings, according to a new study.